Drug‐level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients-Reference-Cited by-同舟云学术

Drug‐level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients

Published:2022-07-20 Issue:4 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Kim Ock‐Hwa¹^ORCID,Shim Tae Sun²^ORCID,Jo Kyung‐Wook²^ORCID

Affiliation:

1. Division of Pulmonology and Critical Care Medicine Department of Internal Medicine Chungnam National University Sejong Hospital Sejong Republic of Korea

2. Division of Pulmonology and Critical Care Medicine Department of Internal Medicine Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13893

Reference37 articles.

1. Mycobacterium tuberculosisInfection in Solid‐Organ Transplant Recipients: Impact and Implications for Management

2. Tuberculosis after Solid‐Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis in kidney transplant candidates and recipients;World Journal of Transplantation;2024-09-18

2. Drug–drug interactions in the management of non-tuberculous mycobacterial infections;Frontiers in Microbiology;2024-09-05

3. ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics;Current Drug Targets;2024-02

4. Kidney transplantation in patients on anti‐tubercular therapy: A single centre observational study;Transplant Infectious Disease;2024-01-25